| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID12886 |
| PMID | 23915341 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | NA |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | 4121.48 |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | LC/ESI MS-MS |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | 2.59E-04 |
| Software | Bioworks Browser |
| Length of Peptide | NA |
| Cancer Type | Acute myeloid leukemia (AML) |
| Database for Peptide search | IPI Human Database ( v3.45 ) |
| Modification | NA |
| Number of Patients | "72 healthy controls were selected from adult healthy examinees without any diseases. In addition, 37 serum samples were obtained from AML patients with hematologic CR and 30 serum samples from refractory & relapsed AML patients." |
| Regulation/Differential Expression | Downregulated in AML vs healthy |
| Validation | NA |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |